DoubleChecks

What was claimed

New Nature study proves SARS-CoV-2 infection (not vaccines) reactivates latent viruses like EBV/CMV causing Long COVID, while vaccines reduce Long COVID risk

Our verdict

Needs caution

The IMPACC study participants were hospitalized, unvaccinated, and primarily exposed to ancestral SARS-CoV-2 strains, limiting direct applicability to contemporary vaccinated populations, milder infections, and newer variants. The study's findings may not generalize broadly. The Nature study does not establish causation between virus reactivation and clinical outcomes. Experts noted the authors 'carefully do NOT attribute any disease (including long COVID) to [the reactivated viruses]' and 'it is not clear whether they play any role in disease production'. The causal mechanism remains unproven.

All 3 AI systems agree20 sources citedChecked Aug 11, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

Study population was representative of general population

Incorrect90%
1 AI checked

Virus reactivation causes Long COVID

Can’t verify60%
1 AI checked

A new Nature study proves SARS-CoV-2 infection (not vaccines) reactivates latent viruses like EBV/CMV causing Long COVID.

Verified87%
3 of 7 AIs agree·Claude: Misleading, ChatGPT: Misleading, Perplexity: Incorrect, Perplexity: Misleading

Vaccines reduce Long COVID risk

Verified95%
1 AI checked

Verified against 20 sources

science.orgnature.compmc.ncbi.nlm.nih.govnature.compmc.ncbi.nlm.nih.govmedicalxpress.compubmed.ncbi.nlm.nih.govmedrxiv.orgtandfonline.comacademic.oup.comcidrap.umn.edupmc.ncbi.nlm.nih.govnature.comnature.compmc.ncbi.nlm.nih.govnature.combraininflammation.orgpmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govmdpi.com

Detailed Analysis

The claim mixes a broadly supported finding with an overstatement. Recent Nature reporting and the Nature paper support that SARS-CoV-2 infection can reactivate latent viruses such as EBV and CMV, and that this reactivation is associated with severe COVID-19 and some long-COVID outcomes, but the study does not prove causation. The statement that vaccines reduce Long COVID risk is plausible and supported by other evidence, but it is not established by the cited Nature study itself, so the wording is misleading.

Why this verdict

  • The claim mixes a broadly supported finding with an overstatement.
  • Recent Nature reporting and the Nature paper support that SARS-CoV-2 infection can reactivate latent viruses such as EBV and CMV, and that this reactivation is associated with severe COVID-19 and some long-COVID outcomes, but the study does not prove causation.
  • The statement that vaccines reduce Long COVID risk is plausible and supported by other evidence, but it is not established by the cited Nature study itself, so the wording is misleading.

Claims checked

The study proves that this reactivation causes Long COVID.

Incorrect93%
The paper explicitly says it does not establish causation between viral reactivation and clinical outcomes, only an association.

This claim may mislead readers without added context.

The reactivation was caused by SARS-CoV-2 infection, not vaccines.

Misleading81%
The study focuses on infection in hospitalized patients and does not test vaccines as the cause of reactivation. Framing it as ruling out vaccines goes beyond what the study shows.

This claim may mislead readers without added context.

COVID-19 vaccines reduce Long COVID risk.

Verified80%
This is supported by broader evidence outside the Nature study, but the provided sources do not directly establish it from the same study. The claim is generally accurate, but it is not the paper’s main finding.

What other AI think

The claim contains both accurate and misleading elements. The Nature study does confirm SARS-CoV-2 reactivates latent viruses like EBV/CMV, and vaccines do reduce Long COVID risk. However, the study explicitly does NOT "prove" causation, and the claim overstates the study's findings by using definitive language where the researchers were cautious.

Why this verdict

  • The claim contains both accurate and misleading elements.
  • The Nature study does confirm SARS-CoV-2 reactivates latent viruses like EBV/CMV, and vaccines do reduce Long COVID risk.
  • However, the study explicitly does NOT "prove" causation, and the claim overstates the study's findings by using definitive language where the researchers were cautious.

Claims checked

Study population was representative of general population

Incorrect90%
The IMPACC study participants were hospitalized, unvaccinated, and primarily exposed to ancestral SARS-CoV-2 strains, limiting direct applicability to contemporary vaccinated populations, milder infections, and newer variants. The study's findings may not generalize broadly.

This claim may mislead readers without added context.

New Nature study proves SARS-CoV-2 infection reactivates latent viruses like EBV/CMV

Misleading95%
The Nature study demonstrates that reactivation of Herpesviridae (including EBV and CMV) correlates with disease severity and clinical outcomes. However, the study explicitly states 'our results do not establish causation between virus reactivation and clinical outcomes'. The word 'proves' overstates the evidence; the study shows correlation, not causation.

This claim may mislead readers without added context.

Virus reactivation causes Long COVID

Can’t verify60%
The Nature study does not establish causation between virus reactivation and clinical outcomes. Experts noted the authors 'carefully do NOT attribute any disease (including long COVID) to [the reactivated viruses]' and 'it is not clear whether they play any role in disease production'. The causal mechanism remains unproven.
The statement mixes accurate findings with overstated causal claims. Studies (including high-profile Nature papers) report associations between SARS-CoV-2 infection and reactivation of latent herpesviruses and higher anti-EBV responses in people with long COVID. Evidence that vaccination reduces the risk of long COVID is supported by multiple observational reviews, but both causation and the magnitude of effects remain uncertain.

Why this verdict

  • The statement mixes accurate findings with overstated causal claims.
  • Studies (including high-profile Nature papers) report associations between SARS-CoV-2 infection and reactivation of latent herpesviruses and higher anti-EBV responses in people with long COVID.
  • Evidence that vaccination reduces the risk of long COVID is supported by multiple observational reviews, but both causation and the magnitude of effects remain uncertain.

Claims checked

A new Nature study proves SARS-CoV-2 infection (not vaccines) reactivates latent viruses like EBV/CMV causing Long COVID.

Misleading90%
Nature and related studies report associations between SARS-CoV-2 infection and markers consistent with EBV (and other herpesvirus) reactivation and higher anti-EBV antibody responses in people with long COVID, but they do not 'prove' causation; evidence is mainly observational and cannot fully exclude confounding or directionality.

This claim may mislead readers without added context.

Vaccines reduce Long COVID risk.

Verified85%
Multiple systematic reviews and meta-analyses of observational studies find that prior COVID-19 vaccination is associated with a lower risk of developing long COVID, though effect sizes vary and evidence quality is generally low-to-moderate.

Share this result

Try DoubleChecks